KPL-404
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for KPL-404, covering 2025-07-22 to 2025-07-22. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess the Safety, Pharmacokinetics, and Efficacy of KPL-404 in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to at Least One Biologic Disease-modifying Anti-rheumatic Drug or a Janus Kinase Inhibitor [Phase 2]